entertainment -WSS

entertainment

author：Wikipedia 2025-09-29 00:39:12 - browse：54

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： At ASCO, AstraZeneca reports strong data for breast cancer drug

WSS

The United States must get value

The Pandemic Treaty must support building strong health systems

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

BMI, flaws aside, is found to be useful estimate of body fat in youth

HHS suspends federal funding for EcoHealth Alliance

CVS is willing to dump 10% of its Medicare Advantage members

knowledge

entertainment

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How to increase colonoscopy rates? Looks like an AI can help

Guidelines to prevent youth baseball injuries need more muscle

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

See how much Covid

Virginia high school admissions case could be legal follow

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Activists slam private health insurers over coverage restrictions

Cherokee Nation medical school graduates its first class

hotspot

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

CVS is willing to dump 10% of its Medicare Advantage members

Ripples from Flovent's discontinuation is killing children with asthma

Intellia reports positive results for its CRISPR

Fertility clinic egg and embryo storage is a disaster

explore

focus

explore

Wikipedia